SLC16A9 and colorectal cancer: Fernandez-Ranvier et al found that SLAC16A9 could be a good diagnostic target for distinguishing benign from malignant adrenocortical tumors.[29] Lim et al found that it was highly expressed in diffuse large B-cell lymphoma.[30] What's more, an informatic analysis have found SLC16A9 had potential diagnostic value for indicating the occurrence of colorectal cancer.[31] In our study, we find that SLC16A9 is highly expressed in colon cancer which leads to improved OS.